Complete Remission from Intralesional Talimogene Laherparepvec for Regionally Advanced Merkel Cell Carcinoma in an Immunocompromised Solid Organ Transplant Patient.

Kelsey E. Hirotsu,Vivian Hua, Anhthy T. Tran, Laura Morris,Sunil A. Reddy,Bernice Y. Kwong,Lisa C. Zaba

JAAD case reports（2021）

引用 4|浏览20

暂无评分

摘要

Merkel cell carcinoma (MCC) is a rare aggressive cutaneous neuroendocrine tumor with a high risk of locoregional recurrence and distant metastasis. Immune checkpoint inhibitors (ICIs), avelumab and pembrolizumab, have been approved by the US Food and Drug Administration for the treatment of advanced MCC.1

查看译文

关键词

cutaneous oncology,herpes,immunosuppressed,Merkel cell carcinoma,oncodermatology,talimogene laherparepvec,transplant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要